Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Inhibitor of DNA Binding 4 (ID4)

  • Giulia Fontemaggi
  • Giovanni Blandino
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_146

Synonyms

 bHLHb27;  ID4;  IDB4

Historical Background

Transcription factors containing a basic helix-loop-helix (bHLH) motif regulate expression of tissue-specific genes in a number of mammalian and insect systems, playing a key role in the differentiation processes. These proteins contain an HLH domain, which mediates homo- and heterodimerization, plus an adjacent DNA-binding region rich in basic amino acids. The bHLH proteins bind to a DNA sequence known as E-box (CANNTG).

Dominant-negative HLH proteins encoded by Id-related genes, such as Id4, also contain the HLH-dimerization domain but lack the DNA-binding basic domain. Consequently, Id proteins inhibit binding to DNA and transcriptional transactivation by heterodimerization with bHLH proteins (Lasorella et al. 2014). In mammals there are four known Id gene family members, known as Id1, Id2, Id3, and Id4. The identity between the HLH regions of Id proteins is very high, while the remaining regions of the proteins are not...

This is a preview of subscription content, log in to check access.

References

  1. Andres-Barquin PJ, Hernandez MC, Israel MA. Id4 expression induces apoptosis in astrocytic cultures and is down-regulated by activation of the cAMP-dependent signal transduction pathway. Exp Cell Res. 1999;247(21):347–55.CrossRefPubMedGoogle Scholar
  2. Baker LA, Holliday H, Swarbrick A. ID4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA1 function in basal-like breast cancer. Endocr Relat Cancer. 2016 Sep;23(9):R381–92.CrossRefPubMedGoogle Scholar
  3. Bedford L, Walker R, Kondo T, van Crüchten I, King ER, Sablitzky F. Id4 is required for the correct timing of neural differentiation. Dev Biol. 2005;280:386–95.CrossRefPubMedGoogle Scholar
  4. Beger C, Pierce LN, Kruger M, Marcusson EG, Robbins JM, Welcsh P, Welch PJ, Welte K, King MC, Barber JR, Wong-Staal F. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):130–5.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Fontemaggi G, Dell’Orso S, Trisciuoglio D, Shay T, Melucci E, Fazi F, Terrenato I, Mottolese M, Muti P, Domany E, Del Bufalo D, Strano S, Blandino G. The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis. Nat Struct Mol Biol. 2009;16(10):1086–93.CrossRefPubMedGoogle Scholar
  6. Fontemaggi G, Dell’Orso S, Muti P, Blandino G, Strano S. Id2 gene is a transcriptional target of the protein complex mutant p53/E2F1. Cell Cycle. 2010;9(12):2464–6.CrossRefPubMedGoogle Scholar
  7. Hirai S, Miwa A, Ohtaka-Maruyama C, Kasai M, Okabe S, Hata Y, Okado H. RP58 controls neuron and astrocyte differentiation by downregulating the expression of Id1-4 genes in the developing cortex. EMBO J. 2012 Mar 7;31(5):1190–202.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Huang J, Vogel G, Yu Z, Almazan G, Richard S. Type II arginine methyltransferase PRMT5 regulates gene expression of inhibitors of differentiation/DNA binding Id2 and Id4 during glial cell differentiation. J Biol Chem. 2011;286(52):44424–32.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Jen Y, Manova K, Benezra R. Each member of the Id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis. Dev Dyn. 1997;208:92–106.CrossRefPubMedGoogle Scholar
  10. Jeon HM, Jin X, Lee JS, Oh SY, Sohn YW, Park HJ, Joo KM, Park WY, Nam DH, DePinho RA, Chin L, Kim H. Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling. Genes Dev. 2008;22(15):2028–33.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Jeon HM, Sohn YW, Oh SY, Kim SH, Beck S, Kim S, Kim H. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2. Cancer Res. 2011;71(9):3410–21.CrossRefPubMedGoogle Scholar
  12. Kuzontkoski PM, Mulligan-Kehoe MJ, Harris BT, Israel MA. Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels. Oncogene. 2010;29(26):3793–802.CrossRefPubMedGoogle Scholar
  13. Lasorella A, Benezra R, Iavarone A. The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat Rev Cancer. 2014;14:77–91.CrossRefPubMedGoogle Scholar
  14. Liang Y, Bollen AW, Nicholas MK, Gupta N. Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas. BMC Clin Pathol. 2005;5:6.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Napolitano M, Comegna M, Succoio M, Leggiero E, Pastore L, Faraonio R, Cimino F, Passaro F. Comparative analysis of gene expression data reveals novel targets of senescence-associated microRNAs. PLoS One. 2014;9:e98669.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Park SJ, Kim RJ, Nam JS. Inhibitor of DNA-binding 4 contributes to the maintenance and expansion of cancer stem cells in 4T1 mouse mammary cancer cell line. Lab Anim Res. 2011 Dec; 27(4):333–8.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Patel D, Morton DJ, Carey J, Havrda MC, Chaudhary J. Inhibitor of differentiation 4 (ID4): from development to cancer. Biochim Biophys Acta. 2015;1855(1):92–103.PubMedGoogle Scholar
  18. Rahme GJ, Israel MA. Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function. Oncogene. 2015;34(1):53–62.CrossRefPubMedGoogle Scholar
  19. Ren Y, Cheung HW, von Maltzhan G, Agrawal A, Cowley GS, Weir BA, Boehm JS, Tamayo P, Karst AM, Liu JF, Hirsch MS, Mesirov JP, Drapkin R, Root DE, Lo J, Fogal V, Ruoslahti E, Hahn WC, Bhatia SN. Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4. Sci Transl Med. 2012;4:147ra112.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Roldán G, Delgado L, Musé IM. Tumoral expression of BRCA1, estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer. Can Biol Therapy. 2006;5:505–10.CrossRefGoogle Scholar
  21. The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carci- noma. Nature. 2011;474:609–15.CrossRefGoogle Scholar
  22. Umetani N, Mori T, Koyanagi K, et al. Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer. Oncogene. 2005;24:4721–7.CrossRefPubMedGoogle Scholar
  23. Yun K, Mantani A, Garel S, Rubenstein J, Israel MA. Id4 regulates neural progenitor proliferation and differentiation in vivo. Development. 2004;131:5441–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Oncogenomic and Epigenetic UnitRegina Elena Cancer InstituteRomeItaly